Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Knox

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|August 2, 2016
Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cellsMiriam Carr, Andrew J S Knox, David G Lloyd, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 30, 2008
Beta-lactam type molecular scaffolds for antiproliferative activity: synthesis and cytotoxic effects in breast cancer cellsMary J Meegan, Miriam Carr, Andrew J S Knox, et al.
Journal of Medicinal Chemistry|August 20, 2013
Vinyl sulfone-based peptidomimetics as anti-trypanosomal agents: design, synthesis, biological and computational evaluationElizabeth Dunny, William Doherty, Paul Evans, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 14, 2007
Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivativesHelena M Smith, Andrew J S Knox, Daniela M Zisterer, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cellsMary J Meegan, Irene Barrett, Jochen Zimmermann, et al.
Drug Discovery Today|March 15, 2006
Oncology exploration: charting cancer medicinal chemistry spaceDavid G Lloyd, Georgia Golfis, Andrew J S Knox, et al.
European Journal of Medicinal Chemistry|October 12, 2010
Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effectsMiriam Carr, Lisa M Greene, Andrew J S Knox, et al.
Journal of Medicinal Chemistry|October 9, 2007
Target specific virtual screening: optimization of an estrogen receptor screening platformAndrew J S Knox, Mary J Meegan, Vladimir Sobolev, et al.
Bioorganic & Medicinal Chemistry|September 17, 2011
Lead identification of β-lactam and related imine inhibitors of the molecular chaperone heat shock protein 90Niamh M O'Boyle, Andrew J S Knox, Trevor T Price, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 13, 2010
Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effectsIrene Barrett, Miriam Carr, Niamh O'Boyle, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Enzyme Inhibition and Medicinal Chemistry|August 2, 2016
Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cellsMiriam Carr, Andrew J S Knox, David G Lloyd, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 30, 2008
Beta-lactam type molecular scaffolds for antiproliferative activity: synthesis and cytotoxic effects in breast cancer cellsMary J Meegan, Miriam Carr, Andrew J S Knox, et al.
Journal of Medicinal Chemistry|August 20, 2013
Vinyl sulfone-based peptidomimetics as anti-trypanosomal agents: design, synthesis, biological and computational evaluationElizabeth Dunny, William Doherty, Paul Evans, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 14, 2007
Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivativesHelena M Smith, Andrew J S Knox, Daniela M Zisterer, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cellsMary J Meegan, Irene Barrett, Jochen Zimmermann, et al.
Drug Discovery Today|March 15, 2006
Oncology exploration: charting cancer medicinal chemistry spaceDavid G Lloyd, Georgia Golfis, Andrew J S Knox, et al.
European Journal of Medicinal Chemistry|October 12, 2010
Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effectsMiriam Carr, Lisa M Greene, Andrew J S Knox, et al.
Journal of Medicinal Chemistry|October 9, 2007
Target specific virtual screening: optimization of an estrogen receptor screening platformAndrew J S Knox, Mary J Meegan, Vladimir Sobolev, et al.
Bioorganic & Medicinal Chemistry|September 17, 2011
Lead identification of β-lactam and related imine inhibitors of the molecular chaperone heat shock protein 90Niamh M O'Boyle, Andrew J S Knox, Trevor T Price, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 13, 2010
Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effectsIrene Barrett, Miriam Carr, Niamh O'Boyle, et al.
Pageof 4